To The Moon

Selling covered call options (sell covered call) is a strategy adopted by many large funds. It can also be used by retail investors in the US stock market.You can get income while holding it. This strategy is very suitable for stocks that have long-term positions, but they have not moved but they are not in a bearish position recently or are in a bearish position recently. It can be a good strategy for mature investors to roll over when holding some targets for a long time. Income comparison Assume that investors hold 200 shares of Amazon from January 1 to December 17, 2021 If there is no operation during the holding period, the final total assets will be USD 675,484 If the covered call strategy is carried out, it will be operated once a week; if 100 shares are sold after the exercise, ano

Gene-editing company $Intellia Therapeutics(NTLA)$ has just released some new data that shows the company has the ability to continue to lead the gene-editing field. While there is still much work to be done to confirm and profit from Intellia's new findings, none of its peers have been able to cross the bridge.New proof-of-concept stuff? Intellia's main goal is to develop gene editing therapies that can correct congenital genetic problems. The lead project NTLA-2001 aims to treat a rare disease called transthyroxin amyloidosis (ATTR) by knocking out the gene for a dysfunctional protein that causes heart failure and shortness of breath.Management forecasts that the market for ATTR drugs will reach $11 billion a year by 2029, which represents signi

Synopsis: Are AI stocks trading at unreasonably expensive valuations? Could the upcoming earnings reports from Tesla, Amazon, and Apple boost their stock prices? What are the risks, given that their prices have soared from their 2023 lows? Please click here to access the webinar on July 16th at 7.30 pm.